secwatch.observer — SEC 8-K summary
======================================

Issuer:     Cocrystal Pharma, Inc. (COCP)
CIK:        0001412486
Form:       8-K
Filed at:   2024-01-08T23:59:59+00:00
Accession:  0001493152-24-001662
Event type: other_material
Sentiment:  neutral
Materiality: 0.25
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Cocrystal Pharma provides corporate presentation; details not disclosed in filing
--------------------------------------------------------------------------------

- Cocrystal Pharma (COCP) presented to the investment community on January 8, 2024.
- Slide deck furnished as Exhibit 99.1; specific content not included in this 8-K text.
- Presentation likely covers pipeline and strategy; no material new data are confirmed from filing alone.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1412486/000149315224001662/0001493152-24-001662-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1412486/000149315224001662/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-001662

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer